Financial News
Latest News about JNJ
Recent news which mentions JNJ
5 Phenomenal Stocks in Warren Buffett's "Secret" Portfolio That Are Screaming Buys in 2024
December 11, 2023
From Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 08, 2023
From Benzinga
7 Tech Stocks to Light Up Your Portfolio This Holiday Season
December 08, 2023
From InvestorPlace
Walgreens’ stock soars 8% to lead Dow gainers but is still on track for worst year since 1972
December 07, 2023
From MarketWatch
Investing in the Aging Population: 3 Healthcare Stocks to Watch
December 07, 2023
From InvestorPlace
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
December 07, 2023
From Benzinga
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
From Benzinga
Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential
December 06, 2023
From InvestorPlace
Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy
December 06, 2023
Tickers
JNJ
From Benzinga
Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3
December 05, 2023
From InvestorPlace
Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24
December 05, 2023
Tickers
JNJ
From Benzinga
Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits
December 05, 2023
From Benzinga
The 7 Best Ways to Invest $1,000 in the Stock Market Now
December 04, 2023
From InvestorPlace
Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure
December 04, 2023
Tickers
JNJ
From Benzinga
Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
December 03, 2023
From Benzinga
From Motley Fool
Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
December 02, 2023
From Benzinga
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections
December 01, 2023
From Benzinga
From Benzinga
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
December 01, 2023
From InvestorPlace
Warren Buffett Reduced This Long-Time Berkshire Hathaway Holding by 67%. Should Investors Follow His Lead?
December 01, 2023
From Motley Fool
7 Blue-Chip Stocks to Buy for 2024, According to AI
November 30, 2023
From InvestorPlace
Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns
November 30, 2023
From InvestorPlace
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
November 30, 2023
From InvestorPlace
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
From Benzinga
The 7 Biggest Dividend Stocks in Warren Buffett’s Portfolio
November 29, 2023
From InvestorPlace
2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now
November 28, 2023
From Motley Fool
Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering
November 28, 2023
From Benzinga
3 Robotics Stocks That Could Be Multibaggers in the Making
November 28, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
